6ZB0
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-benzyl-N-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E+ SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-08-07 |
Detector | RIGAKU SATURN A200 |
Wavelength(s) | 1.54178 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 72.106, 52.758, 32.318 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 29.491 - 1.613 |
Rwork | 0.139 |
R-free | 0.17750 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | in house structure |
RMSD bond length | 0.006 |
RMSD bond angle | 1.325 |
Data reduction software | XDS |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 36.050 | 1.700 |
High resolution limit [Å] | 1.610 | 1.610 |
Rmerge | 0.019 | 0.065 |
Number of reflections | 15692 | 1924 |
<I/σ(I)> | 31.9 | 11.2 |
Completeness [%] | 95.5 | 81.8 |
Redundancy | 2.7 | 1.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 293 | 30% PEG 300, 0.1M MES buffer pH6.5 |